Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE104 in Postpartum Depression
NCT06342310Phase 2Completed
- Sponsor
- Reunion Neuroscience
- Start
- Jun 2024
- Primary completion
- May 2025
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of RE104 in postpartum depression (PPD), sponsored by Reunion Neuroscience. Started Jun 2024; status: completed.
02
Drugs
RE104
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT06342310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06342310.